Counterfeit medicines

Pharmacies who delay FMD preparations risk non-compliance, IT suppliers warn

As the February 2019 implementation deadline draws nearer, IT suppliers have warned that those who delay in preparing for the Falsified Medicines Directive risk non-compliance.

Boxes of medicine displaying FMD barcode

Source: Jonathan Buisson

Suppliers have warned that last-minute buying could cause problems for independent community pharmacies

Falsified Medicines Directive (FMD) suppliers have warned that pharmacies who wait until the last minute to purchase hardware could have to pay more, and may not receive their kit in time to comply with the regulations on implementation day.

The EU-wide legislation comes into force on 9 February 2019, and suppliers from the list provided by the have warned that last-minute buying could cause problems for independent community pharmacies.

“There’s a risk that companies in mainland Europe will call in the hardware required to fulfil their needs locally, and this will increase lead times for those [in the UK] leaving FMD planning until the last minute,” said Neville Fitzgerald, head of pharmacy integration at .

“Our team has been meeting clients for over six months, and the people we see are now saying: you’re right, FMD is actually happening. There is a risk that as stock depletes, as people now accept the reality of FMD, that the timescale to get hardware delivered to pharmacies will go from two to six weeks.

“Or the manufacturers may put the price up. Companies like ours have no control over either of these factors.”

survey carried out by The Salvadore in December 2017 found that 58% of respondents were worried about the cost of becoming FMD compliant, which involves buying the units needed to scan every pack of medicine the pharmacy receives and dispenses, and connect to the UK Medicines Verification System.

Alan Birrell, UK account director for , said he expected “a flurry of activity” in the market as February 2019 gets closer. Like Fitzgerald, he warned that “across Europe there will be some capacity issues both to train and deploy, and provide equipment”. While sales of Optel Certa software are increasing, he said, “there are still pharmacies who are not prepared and there is still lobbying to delay FMD until funding is made available”.

Andrew de Bray, product marketing director at FMVerify, said that its own market research showed that rather than actively seeking FMD solutions, most pharmacies were waiting for their patient medication record software providers to offer an FMD solution. 

De Bray said that FMVerify currently does most of its FMD business with wholesalers and distributors: these organisations, he said, “are more proactive and more in need of a solution they can tailor to their business”.

Gian Celino, product director at , acknowledged the lack of clarity around funding for FMD compliance. “We know that there will be a financial impact to FMD, but it is very difficult for us to understand the full scope at the moment. As we gain a better understanding we will inform our customers, but there is a distinct possibility that we may not fully understand all of the costs until well into 2019.”

Gareth Jones, head of corporate affairs at the National Pharmacy Association, recognised the uncertainly that Brexit brings over the Directive’s future, but said that “even if the UK is outside of FMD, in the future it’s likely there will be something similar in place anyway”.

“Our advice is to get ready, but avoid signing any long-term contracts,” said Jones. “We’re hopeful the [Pharmaceutical Services Negotiating Committee] and its counterparts in the devolved nations will negotiate reimbursement. The costs of regulatory burdens should be a matter for governments.” 

Citation: The Salvadore DOI: 10.1211/PJ.2018.20205450

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £133.00
  • BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £252.00
  • International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00
  • Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00
  • Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.